2013•China Health Care & NutritionRequires access

Nebulized ipratropium bromide in the treatment of acute exacerbations of chronic obstructive pulmonary disease curative effect observation

Jinghan Zhang

Open publisher page 0 citations

Abstract

Objective To observe the nebulized ipratropium bromide aerosol in the treatment of chronic obstructive pulmonary disease(COPD) in acute stage of attack effect.Methods 80 cases of hospitalized patients with acute exacerbations of COPD,were randomly divided into treatment group and control group with 40 cases in each group.2 groups were observed before and after treatment in patients with dyspnea score,expectoration score,pulmonary function and clinical effects of changes.Results After 1 weeks treatment in two groups of patients with dyspnea score,expectoration score,pulmonary function,clinical efficacy were significantly decreased(P 0.05 or P 0.01),and the treatment group decreased more than that of the control group obviously(P 0.05).Conclusion Nebulized ipratropium bromide in the treatment of acute COPD patients a significant effect,is worth the clinical promoted application.

About this research paper

What this paper is about

Objective To observe the nebulized ipratropium bromide aerosol in the treatment of chronic obstructive pulmonary disease(COPD) in acute stage of attack effect.Methods 80 cases of hospitalized patients with acute exacerbations of COPD,were randomly divided into treatment group and control group with 40 cases in each group.2 groups were observed before and after treatment in patients with dyspnea score,expectoration score,pulmonary function and clinical effects of changes.Results After 1 weeks treatment in two groups of patients with dyspnea score,expectoration score,pulmonary function,clinical efficacy were significantly decreased(P 0.05 or P 0.01),and the treatment group decreased more than that of the control group obviously(P 0.05).Conclusion Nebulized ipratropium bromide in the treatment of acute COPD patients a significant effect,is worth the clinical promoted application.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the nebulized ipratropium bromide aerosol in the treatment of chronic obstructive pulmonary disease(COPD) in acute stage of attack effect.Methods 80 cases of hospitalized patients with acute exacerbations of COPD,were randomly divided into treatment group and control group with 40 cases in each group.2 groups were observed before and after treatment in patients with dyspnea score,expectoration score,pulmonary function and clinical effects of changes.Results After 1 weeks treatment in two groups of patients with dyspnea score,expectoration score,pulmonary function,clinical efficacy were significantly decreased(P 0.05 or P 0.01),and the treatment group decreased more than that of the control group obviously(P 0.05).Conclusion Nebulized ipratropium bromide in the treatment of acute COPD patients a significant effect,is worth the clinical promoted application.

Key concepts: Ipratropium bromide, Medicine, COPD, Pulmonary disease, Pulmonary function testing, Anesthesia, Exacerbation, Treatment and control groups

Related papers

Back to paper searchBrowse research topicsOriginal source
Nebulized ipratropium bromide in the treatment of acute exacerbations of chronic obstructive pulmonary disease curative effect observation — Research Paper | ScholarLens